ARCHIVES

Symposium Planned On Hyperthermia

This article is from The Cancer Letter archive.

Vol. 02 No. 17 | April 23, 1976

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

DCT To Announce Three New CRAGs

November 12, 1976

Tobacco Council Grants Total 3,348

July 15, 1988

First Compound From New In Vitro Screening to Enter Clinical Trials

December 5, 1986

Research Advocates Prepare to Face Republican-led Congress

December 19, 2014